DE69128926T2 - Verwendung von N,N'-Bis 3-(ethylamino)propyl-1,7-Heptandiamin und einem zytotoxischen Mittel - Google Patents

Verwendung von N,N'-Bis 3-(ethylamino)propyl-1,7-Heptandiamin und einem zytotoxischen Mittel

Info

Publication number
DE69128926T2
DE69128926T2 DE69128926T DE69128926T DE69128926T2 DE 69128926 T2 DE69128926 T2 DE 69128926T2 DE 69128926 T DE69128926 T DE 69128926T DE 69128926 T DE69128926 T DE 69128926T DE 69128926 T2 DE69128926 T2 DE 69128926T2
Authority
DE
Germany
Prior art keywords
ethylamino
propyl
bis
antineoplastic
cytotoxic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69128926T
Other languages
English (en)
Other versions
DE69128926D1 (de
Inventor
Nellikunja J Prakash
Terry L Bowlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69128926D1 publication Critical patent/DE69128926D1/de
Publication of DE69128926T2 publication Critical patent/DE69128926T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69128926T 1990-12-13 1991-12-12 Verwendung von N,N'-Bis 3-(ethylamino)propyl-1,7-Heptandiamin und einem zytotoxischen Mittel Expired - Fee Related DE69128926T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62681490A 1990-12-13 1990-12-13

Publications (2)

Publication Number Publication Date
DE69128926D1 DE69128926D1 (de) 1998-03-26
DE69128926T2 true DE69128926T2 (de) 1998-06-04

Family

ID=24511975

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69128926T Expired - Fee Related DE69128926T2 (de) 1990-12-13 1991-12-12 Verwendung von N,N'-Bis 3-(ethylamino)propyl-1,7-Heptandiamin und einem zytotoxischen Mittel

Country Status (11)

Country Link
EP (1) EP0490380B1 (de)
JP (1) JPH04275233A (de)
KR (1) KR100195423B1 (de)
AT (1) ATE163264T1 (de)
AU (1) AU648846B2 (de)
DE (1) DE69128926T2 (de)
DK (1) DK0490380T3 (de)
ES (1) ES2113870T3 (de)
GR (1) GR3026432T3 (de)
IE (1) IE914331A1 (de)
ZA (1) ZA919695B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0819432B1 (de) * 1996-01-31 2004-03-24 Japan Science and Technology Corporation Antitumormittel mit silizium und stickstoff enthaltenden verbindungen als hauptbestandteil
US6274561B1 (en) 1997-01-29 2001-08-14 Japan Science & Technology Corp. Antitumor agents comprising as the principal compounds containing silicon and nitrogen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA88600B (en) * 1987-02-03 1988-07-28 Merrell Dow Pharmaceuticals Inc. Novel polyamine derivatives
EP0378146B1 (de) * 1989-01-10 1995-03-29 Merrell Pharmaceuticals Inc. Polyamin-Derivate als antineoplastische Mittel
ZA903804B (en) * 1989-05-23 1991-03-27 Merrell Dow Pharma A method of potentiating cell-mediated immunity utilizing polyamine derivatives

Also Published As

Publication number Publication date
ATE163264T1 (de) 1998-03-15
DK0490380T3 (da) 1998-09-23
ES2113870T3 (es) 1998-05-16
GR3026432T3 (en) 1998-06-30
DE69128926D1 (de) 1998-03-26
AU648846B2 (en) 1994-05-05
KR100195423B1 (ko) 1999-06-15
IE914331A1 (en) 1992-06-17
EP0490380A3 (en) 1993-03-10
ZA919695B (en) 1992-09-30
JPH04275233A (ja) 1992-09-30
EP0490380B1 (de) 1998-02-18
AU8890791A (en) 1992-06-18
EP0490380A2 (de) 1992-06-17
KR920011481A (ko) 1992-07-24

Similar Documents

Publication Publication Date Title
HU0301601D0 (en) Bis(n-substituted)-staurosporine derivatives, their use and pharmaceutical composition containing thereof
HK1005987A1 (en) Taste-masked pharmaceutical compositions
DE69432559T2 (de) Verwendung von eisenbindenden polymeren zur herstellung eines medikaments zur oralen verabreichung
IL96995A0 (en) Pharmaceutical compositions containing pimobendan and their preparation
NO902800L (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
PH30083A (en) Treatment of lower urinary tract disorders
ES2080736T3 (es) Uso de 2,3,4,5-tetrahidro-1h-3-benzazepinas en el tratamiento de trastornos neurologicos.
DE69014666D1 (de) Abgabe von cytotoxischen Mitteln.
DE59005456D1 (de) Cytostatische und cytotoxische Wirkstoffkombination zur Anwendung in therapeutischen Verfahren.
DE69128926D1 (de) Verwendung von N,N'-Bis 3-(ethylamino)propyl-1,7-Heptandiamin und einem zytotoxischen Mittel
DE515995T1 (de) N-(5-thioxo-l-propyl)-l-cystein und derivate, deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
GR3021231T3 (en) Process for preparing stable hydrophilic or ambiphic cream preparations containing vesicular composnents and their use
ATE182149T1 (de) Neue 3-phenylsulfonyl-3,7- diazabicyclo(3,3,1)nonan-verbindungen enthaltende arzneimittel
ES2044100T4 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
ATE28566T1 (de) Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und ein amin.
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
Palani Professor Dr. N. Subbu Reddiar's contributions for the enrichment of Tamil
GB8906190D0 (en) Improvements in chemical compounds
ATE10095T1 (de) 10-substituierte 5-cyanmethylen-10,11-dihydrodibenzo-(a,d)-cycloheptene, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
DE69409633T2 (de) Transdermal behandlung von krebs mit wasserunlöslichem s-camtothecin mit geschlossenem lactoring

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee